JSM 2016 Online Program

Keyword Search

Sessions Were Renumbered as of May 19.

Legend:
CC-W = McCormick Place Convention Center, West Building,   CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,   UC= Conference Chicago at University Center
* = applied session       ! = JSM meeting theme

Keyword Search Criteria: sample size re-estimation returned 8 record(s)

Monday, 08/01/2016

Best Practices for Interim Analysis in Clinical Trials
Jiang Hu, FDA

Tuesday, 08/02/2016

Case Study: How Promising Is the VALOR Trial for the Future of Adaptive Designs?
Yannis Jemiai, Cytel
10:55 AM

Wednesday, 08/03/2016

Unblinded Sample Size Re-Estimation in Bioequivalence Trials with Small Sample Sizes
Sam Hsiao, Cytel; Lingyun Liu, Cytel
8:35 AM

Adaptive Multi-Arm Multi-Stage Group Sequential Designs
Cyrus Mehta, Cytel; Pranab Ghosh, Cytel
9:00 AM

Blinded Sample Size Re-Estimation in Demonstrating Biosimilarity
Lingyun Liu, Cytel; Emmanuelle Vincent, Cytel
9:05 AM

Sample Size Re-Estimation in a Two-Stage Cross-Over Trial for Testing for Average Bioequivalence
Byron Jones, Novartis Pharma; Will Maurer, Novartis Pharma AG; Ying Chen, Shanghai University of Finance and Economics
9:20 AM

Adaptive Enrichment with Subpopulation Selection at Interim
Xiang Ling, FDA/CDER; Sue-Jane Wang, FDA; Kun Jin, FDA/CDER; Hsien-Ming James Hung, FDA
9:35 AM

Thursday, 08/04/2016

Comparison Beyond Power: Sample Size Re-Estimation vs. Group Sequential Design
Lei Shu, Astellas Pharma; Charles Liu, Astellas Pharma; Matt Rosales, Astellas Pharma
11:05 AM

JSM 2016 Online Program

Keyword Search

ASA Meetings Department

Share